New hope for stubborn liver disease: trial tests Second-Line drug
Disease control
Ongoing
This study is testing whether a drug called pemafibrate (K-808) can help control primary biliary cholangitis (PBC), a chronic liver disease, in people whose liver tests remain high despite taking standard medications. About 46 adults who haven't responded well to their current PB…
Phase: PHASE2 • Sponsor: Kowa Research Institute, Inc. • Aim: Disease control
Last updated Apr 02, 2026 07:11 UTC